TNG260pembrolizumabTNG260-inducedNSCLCNon-small cell lung cancerNCT05887492immune checkpoint-based therapies
…tial treatment strategy for patients with STK11-mutated tumors. TNG260 in combination with pembrolizumab is currently being evaluated …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: TNG260-induced ×
TNG260-induced
This drug is selected. Its supporting articles are shown below.